AIG
CINC

American International Group’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

American International Group’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,749
Closed -$144K – 3008
2022
Q4 		$144K Buy
11,749
+2,234
+23% +$53.2K ﹤0.01% 2331
2022
Q3 		$312K Buy
9,515
+3,243
+52% +$91.6K ﹤0.01% 1871
2022
Q2 		$118K Buy
6,272
+511
+9% +$9.78K ﹤0.01% 2503
2022
Q1 		$101K Buy
+5,761
New +$118K ﹤0.01% 2597

American International Group's CINC Position: Q1 2023 in Review

American International Group sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 11,749 shares — an estimated $144K sold.

American International Group first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $312K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • American International Group reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • American International Group sold 11,749 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $144K.
  • American International Group first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • American International Group's CinCor Pharma, Inc. Common Stock position peaked at $312K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on American International Group's 13F filing for Q1 2023, filed 12 May 2023.